|
2015 Journal Article Cluster-randomized clinical trial examining the impact of platelet function testing on practice: The Treatment With Adenosine Diphosphate Receptor Inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy studyWang, Tracy Y., Henry, Timothy D., Effron, Mark B., Honeycutt, Emily, Hess, Connie N., Zettler, Marjorie E., Cohen, David J., Baker, Brian A., Berger, Peter B., Anstrom, Kevin J., Angiolillo, Dominick J. and Peterson, Eric D. (2015). Cluster-randomized clinical trial examining the impact of platelet function testing on practice: The Treatment With Adenosine Diphosphate Receptor Inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy study. Circulation-Cardiovascular Interventions, 8 (6). doi: 10.1161/CIRCINTERVENTIONS.114.001712 |
|
2014 Journal Article Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United StatesBae, Jay P., Faries, Douglas E., Ernst, Frank R., Lipkin, Craig, Zhao, Zhenxiang, Moretz, Chad, Lieu, Hsiao D. and Effron, Mark B. (2014). Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United States. Current Medical Research and Opinion, 30 (11), 2207-2216. doi: 10.1185/03007995.2014.941055 |
|
2014 Journal Article Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients High on-treatment platelet reactivity analysis of the TRIPLET trialDiodati, Jean G., Saucedo, Jorge F., Cardillo, Tracy E., Jakubowski, Joseph A., Henneges, Carsten, Effron, Mark B., Lipkin, Fred R., Walker, Joseph R., Duvvuru, Suman, Sundseth, Scott S., Fisher, Harold N. and Angiolillo, Dominick J. (2014). Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients High on-treatment platelet reactivity analysis of the TRIPLET trial. Thrombosis and Haemostasis, 112 (2), 311-322. doi: 10.1160/TH13-09-0747 |
|
2014 Journal Article Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary interventionWang, Tracy Y., Mccoy, Lisa, Henry, Timothy D., Effron, Mark B., Messenger, John C., Cohen, David J., Mark, Daniel B., Stone, Gregg W., Zettler, Marjorie, Singh, Mandeep, Fonarow, Gregg C. and Peterson, Eric D. (2014). Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary intervention. Journal of the American College of Cardiology, 63 (16), 1700-1702. doi: 10.1016/j.jacc.2013.12.012 |
|
2014 Journal Article Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Patients With Stable Coronary Artery Disease Results of the SWAP-2 Study (Switching Anti Platelet-2)Angiolillo, Dominick J., Curzen, Nicholas, Gurbel, Paul, Vaitkus, Paul, Lipkin, Fred, Li, Wei, Jakubowski, Joseph A., Zettler, Marjorie, Effron, Mark B. and Trenk, Dietmar (2014). Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Patients With Stable Coronary Artery Disease Results of the SWAP-2 Study (Switching Anti Platelet-2). Journal of the American College of Cardiology, 63 (15), 1500-1509. doi: 10.1016/j.jacc.2013.11.032 |
|
2013 Journal Article Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trialDiodati, Jean G., Saucedo, Jorge F., French, John K., Fung, Anthony Y., Cardillo, Tracy E., Henneges, Carsten, Effron, Mark B., Fisher, Harold N. and Angiolillo, Dominick J. (2013). Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trial. Circulation-Cardiovascular Interventions, 6 (5), 567-574. doi: 10.1161/CIRCINTERVENTIONS.112.000063 |
|
2013 Journal Article Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathwaysBraun, Oscar O., Angiolillo, Dominick J., Ferreiro, Jose L., Jakubowski, Joseph A., Winters, Kenneth J., Effron, Mark B., Duvvuru, Suman, Costigan, Timothy M., Sundseth, Scott S., Walker, Joseph R., Saucedo, Jorge F., Kleiman, Neal S. and Varenhorst, Christoph (2013). Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways. Thrombosis and Haemostasis, 110 (6), 1223-1231. doi: 10.1160/TH13-03-0263 |
|
2013 Journal Article Adherence and persistence with prasugrel following acute coronary syndrome with percutaneous coronary interventionNordstrom, Beth L., Simeone, Jason C., Zhao, Zhenxiang, Molife, Cliff, McCollam, Patrick L., Ye, Xin and Effron, Mark B. (2013). Adherence and persistence with prasugrel following acute coronary syndrome with percutaneous coronary intervention. American Journal of Cardiovascular Drugs, 13 (4), 263-271. doi: 10.1007/s40256-013-0028-1 |
|
2013 Journal Article TransRadial Education And Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research ConsortiumHess, Connie N., Rao, Sunil V., Kong, David F., Miller, Julie M., Anstrom, Kevin J., Bertrand, Olivier F., Collet, Jean-Philippe, Effron, Mark B., Eloff, Benjamin C., Fadiran, Emmanuel O., Farb, Andrew, Gilchrist, Ian C., Holmes, David R., Jacobs, Alice K., Kaul, Prashant, Newby, L. Kristin, Rutledge, David R., Tavris, Dale R., Tsai, Thomas T., White, Roseann M., Peterson, Eric D. and Krucoff, Mitchell W. (2013). TransRadial Education And Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium. American Heart Journal, 165 (3), 344-353.e1. doi: 10.1016/j.ahj.2012.09.008 |
|
2013 Journal Article Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) studySaucedo, Jorge F., Angiolillo, Dominick J., DeRaad, Roger, Frelinger, Andrew L., Gurbel, Paul A., Costigan, Timothy M., Jakubowski, Joseph A., Ojeh, Clement K., Duvvuru, Suman and Effron, Mark B. (2013). Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) study. Thrombosis and Haemostasis, 109 (2), 347-355. doi: 10.1160/TH12-06-0378 |
|
2011 Journal Article Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational researchChin, Chee Tang, Wang, Tracy Y., Anstrom, Kevin J., Zhu, Baojin, Maa, Jen-Fue, Messenger, John C., Ryan, Kelley A., Davidson-Ray, Linda, Zettler, Marjorie, Effron, Mark B., Mark, Daniel B. and Peterson, Eric D. (2011). Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational research. American Heart Journal, 162 (5), 844-851. doi: 10.1016/j.ahj.2011.08.021 |
|
2011 Journal Article A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 TrialAngiolillo, Dominick J., JoseBadimon, Juan, Saucedo, Jorge F., Frelinger, Andrew L., Michelson, Alan D., Jakubowski, Joseph A., Zhu, Baojin, Ojeh, Clement K., Baker, Brian A. and Effron, Mark B. (2011). A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial. European Heart Journal, 32 (7), 838-846. doi: 10.1093/eurheartj/ehq494 |
|
2011 Journal Article The onset of inhibition of platelet aggregation with prasugrel compared with clopidogrel loading doses using gatekeeping analysis of integrated clinical pharmacology dataZhu, Baojin, Effron, Mark B., Kulkarni, Pandurang M., Li, Ying G., Jakubowski, Joseph A., Miller, Debra L., Baker, Brian A., Luo, Junxiang, Small, David S. and Winters, Kenneth J. (2011). The onset of inhibition of platelet aggregation with prasugrel compared with clopidogrel loading doses using gatekeeping analysis of integrated clinical pharmacology data. Journal of Cardiovascular Pharmacology, 57 (3), 317-324. doi: 10.1097/FJC.0b013e3182073dfb |
|
2010 Journal Article Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary Syndromes Results of the SWAP (SWitching Anti Platelet) StudyAngiolillo, Dominick J., Saucedo, Jorge F., DeRaad, Roger, Frelinger, Andrew L., Gurbel, Paul A., Costigan, Timothy M., Jakubowski, Joseph A., Ojeh, Clement K. and Effron, Mark B. (2010). Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary Syndromes Results of the SWAP (SWitching Anti Platelet) Study. Journal of the American College of Cardiology, 56 (13), 1017-1023. doi: 10.1016/j.jacc.2010.02.072 |
|
2010 Journal Article Enoxaparin in Primary and Facilitated Percutaneous Coronary Intervention A Formal Prospective Nonrandomized Substudy of the FINESSE Trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)Montalescot, Gilles, Ellis, Stephen G., de Belder, Mark A., Janssens, Luc, Katz, Olivier, Pluta, Wladyslaw, Ecollan, Patrick, Tendera, Michal, van Boven, Ad J., Widimsky, Petr, Andersen, Henning R., Betriu, Amadeo, Armstrong, Paul, Brodie, Bruce R., Herrmann, Howard C., Neumann, Franz-Josef, Effron, Mark B., Lu, Jiandong, Barnathan, Elliot S. and Topol, Eric J. (2010). Enoxaparin in Primary and Facilitated Percutaneous Coronary Intervention A Formal Prospective Nonrandomized Substudy of the FINESSE Trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events). Jacc-Cardiovascular Interventions, 3 (2), 203-212. doi: 10.1016/j.jcin.2009.11.012 |
|
2009 Journal Article Response to Letter Regarding Article "Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in the Raloxifene Use for the Heart Trial: Results of Subgroup Analyses by Age and Other Factors"Collins, Peter, Mosca, Lori, Geiger, Mary Jane, Amewou-Atisso, Messan G., Effron, Mark B., Dowsett, Sherie, Grady, Deborah, Kornitzer, Marcel, Barrett-Connor, Elizabeth and Wenger, Nanette K. (2009). Response to Letter Regarding Article "Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in the Raloxifene Use for the Heart Trial: Results of Subgroup Analyses by Age and Other Factors". Circulation, 120 (17), E148-E148. doi: 10.1161/CIRCULATIONAHA.109.876920 |
|
2009 Journal Article 1-Year Survival in a Randomized Trial of Facilitated Reperfusion Results From the FINESSE (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events) TrialEllis, Stephen G., Tendera, Michal, de Belder, Mark A., van Boven, Ad J., Widimsky, Petr, Andersen, Henning R., Betriu, Amadeo, Savonitto, Stefano, Adamus, Jerzy, Peruga, Jan Z., Hamankiewicz, Maciej, Pluta, Waladyslaw, Oldroyd, Keith, Ecollan, Patrick, Janssens, Luc, Armstrong, Paul, Brodie, Bruce R., Herrmann, Howard C., Montalescot, Gilles, Neumann, Franz-Josef, Effron, Mark B., Bamathan, Elliot S. and Topol, Eric J. (2009). 1-Year Survival in a Randomized Trial of Facilitated Reperfusion Results From the FINESSE (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events) Trial. Jacc-Cardiovascular Interventions, 2 (10), 909-916. doi: 10.1016/j.jcin.2009.07.009 |
|
2009 Journal Article Benefit of Facilitated Percutaneous Coronary Intervention in High-Risk ST-Segment Elevation Myocardial Infarction Patients Presenting to Nonpercutaneous Coronary Intervention HospitalsHerrmann, Howard C., Lu, Jiandong, Brodie, Bruce R., Armstrong, Paul W., Montalescot, Gilles, Betriu, Amadeo, Neuman, Franz-Joseph, Effron, Mark B., Barnathan, Elliot S., Topol, Eric J. and Ellis, Stephen G. (2009). Benefit of Facilitated Percutaneous Coronary Intervention in High-Risk ST-Segment Elevation Myocardial Infarction Patients Presenting to Nonpercutaneous Coronary Intervention Hospitals. Jacc-Cardiovascular Interventions, 2 (10), 917-924. doi: 10.1016/j.jcin.2009.06.018 |
|
2009 Journal Article Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial Results of Subgroup Analyses by Age and Other FactorsCollins, Peter, Mosca, Lori, Geiger, Mary Jane, Grady, Deborah, Kornitzer, Marcel, Amewou-Atisso, Messan G., Effron, Mark B., Dowsett, Sherie A., Barrett-Connor, Elizabeth and Wenger, Nanette K. (2009). Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial Results of Subgroup Analyses by Age and Other Factors. Circulation, 119 (7), 922-930. doi: 10.1161/CIRCULATIONAHA.108.817577 |
|
2008 Journal Article Treating Patients With 'Wake-Up' Stroke The Experience of the AbESTT-II TrialAdams, Harold P., Leira, Enrique C., Torner, James C., Barnathan, Elliot, Padgett, Lakshmi, Effron, Mark B. and Hacke, Werner (2008). Treating Patients With 'Wake-Up' Stroke The Experience of the AbESTT-II Trial. Stroke, 39 (12), 3277-3282. doi: 10.1161/STROKEAHA.107.508853 |
